Within this article, I will discuss my suggested strategies for long-term investors within this bear market. A correction is defined as a pullback of 10%. A bear market is widely defined as a drop of 20% from a recent peak. With fear over the economic impacts of the coronavirus pandemic, the market has dropped over … Continue reading A Bear Market (COVID-19 Pandemic)
Stock
Non-Pharm Finance – Part III
Welcome to part three of Non-Pharm Finance. Within this section, we discuss how to start investing by recommending where to put your money and how to diversify your portfolio.
Arena Pharmaceuticals (NASDAQ: ARNA)
Arena Pharmaceuticals, is a company I see value in. The company’s leading pipeline is etrasimod, in which its worldwide Phase 3 trial for the treatment of moderately to severely active ulcerative colitis is currently in the planning process. Click the title of the post to read more.
Zynerba Pharmaceuticals (NASDAQ: ZYNE)
Zynerba Pharmaceuticals, is a company I see value in. From a technical analysis standpoint, the positive uptrend is an attractive characteristic. Also, with the recent pullback, if ZYNE continues to be supported by the exponential moving average (EMA), it is currently at a “good buy” area. Click the title of the post to read more.
Non-Pharm Finance: Part I
Profit while Simulation Trading
Pill Picks 